Beyond platinum: Synthesis, characterization, and in vitro toxicity of Cu(II)-releasing polymer nanoparticles for potential use as a drug delivery vector

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-10

  Harris, Alesha N ^a   Hinojosa, Barbara R ^a   Chavious, Montaleé D ^a   Petros, Robby A ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Copper; Copper ion release; Drug delivery; Hela cells; Oxidative stress; Polymer nanoparticles

Indexed keywords

CANCER CELLS; CARBOXYLATE FUNCTIONAL GROUPS; CELL VIABILITY; COPPER ION RELEASE; DELIVERY VECTOR; HELA CELL; IN-VITRO; METAL RELEASE; PH SENSITIVITY; PH-DEPENDENT; POLYMER NANOPARTICLES; SMALL ORGANIC MOLECULES; WEIGHT PERCENT;

CARBOXYLATION; CELL DEATH; COPPER; DRUG DELIVERY; FREE RADICALS; FUNCTIONAL GROUPS; FUNCTIONAL POLYMERS; METAL IONS; METALS; NANOPARTICLES; OXIDATIVE STRESS; PLATINUM; PLATINUM COMPOUNDS; STRESS ANALYSIS; SYNTHESIS (CHEMICAL); TOXICITY; TRANSITION METAL COMPOUNDS; VECTORS;

FREE RADICAL POLYMERIZATION;

EID: 84856058157     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-445     Document Type: Article

References (38)

1. Petros RA, DeSimone JM: Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010, 9:615-627.
2. Davis ME, Chen Z, Shin DM: Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
3. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC: Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther 2008, 83:761-769.
4. Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ: Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads. J Am Chem Soc 2009, 131:14652-14653.
5. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ: Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 2008, 105:17356-17361.
6. Rieter WJ, Pott KM, Taylor KML, Lin WB: Nanoscale coordination polymers for platinum-based anticancer drug delivery. J Am Chem Soc 2008, 130:11584-11585.
7. Haxton KJ, Burt HM: Polymeric Drug Delivery of Platinum-Based Anticancer Agents. J Pharm Sci 2009, 98:2299-2316.
8. Treiber C, Quadir MA, Voigt P, Radowski M, Xu SJ, Munter LM, Bayer TA, Schaefer M, Haag R, Multhaup G: Cellular Copper Import by Nanocarrier Systems, Intracellular Availability, and Effects on Amyloid beta Peptide Secretion. Biochemistry 2009, 48:4273-4284.
9. Withey ABJ, Chen G, Nguyen TLU, Stenzel MH: Macromolecular Cobalt Carbonyl Complexes Encapsulated in a Click-Cross-Linked Micelle Structure as a Nanoparticle To Deliver Cobalt Pharmaceuticals. Biomacromolecules 2009, 10:3215-3226.
10. Chen H, Ahn R, Van den Bossche J, Thompson DH, O'Halloran TV: Folatemediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol Cancer Ther 2009, 8:1955-1963.
11. Neuse E: Macromolecular Ferrocene Compounds as Cancer Drug Models. J Inorg Organomet Polym Mater 2005, 15:3-31.
12. Spokoyny AM, Kim D, Sumrein A, Mirkin CA: Infinite coordination polymer nano- and microparticle structures. Chem Soc Rev 2009, 38:1218-1227.
13. Della Rocca J, Lin WB: Nanoscale Metal-Organic Frameworks: Magnetic Resonance Imaging Contrast Agents and Beyond. Eur J Inorg Chem 2010, 3725-3734.
14. Gianferrara T, Bratsos I, Alessio E: A categorization of metal anticancer compounds based on their mode of action. J Chem Soc, Dalton Trans 2009, 7588-7598.
15. Jung YW, Lippard SJ: Direct cellular responses to platinum-induced DNA damage. Chem Rev 2007, 107:1387-1407.
16. Messori L, Casini A, Gabbiani C, Sorace L, Muniz-Miranda M, Zatta P: Unravelling the chemical nature of copper cuprizone. J Chem Soc Dalton Trans 2007, 2112-2114.
17. Gasser G, Ott I, Metzler-Nolte N: Organometallic Anticancer Compounds. J Med Chem 2011, 54:3-25.
18. Thubagere A, Reinhard BM: Nanoparticle-Induced Apoptosis Propagates through Hydrogen-Peroxide-Mediated Bystander Killing: Insights from a Human Intestinal Epithelium In Vitro Model. ACS Nano 2010, 4:3611-3622.
19. George S, Pokhrel S, Xia T, Gilbert B, Ji Z, Schowalter M, Rosenauer A, Damoiseaux R, Bradley KA, Mädler L, Nel AE: Use of a Rapid Cytotoxicity Screening Approach To Engineer a Safer Zinc Oxide Nanoparticle through Iron Doping. ACS Nano 2010, 4:15-29.
20. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S: Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells. ACS Nano 2009, 3:279-290.
21. Xia T, Kovochich M, Liong M, Mädler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE: Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties. ACS Nano 2008, 2:2121-2134.
22. Ahamed M, Akhtar MJ, Siddiqui MA, Ahmad J, Musarrat J, Al-Khedhairy AA, Al Salhi MS, Alrokayan SA: Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 2011, 283:101-108.
23. Park E-J, Yi J, Chung K-H, Ryu D-Y, Choi J, Park K: Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett 2008, 180:222-229.
24. Lunov O, Syrovets T, Büchele B, Jiang X, Röcker C, Tron K, Nienhaus GU, Walther P, Mailänder V, Landfester K, Simmet T: The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31:5063-5071.
25. Ahamed M: Toxic response of nickel nanoparticles in human lung epithelial A549 cells. Toxicol in Vitro 2011, 25:930-936.
26. Ahamed M, Siddiqui MA, Akhtar MJ, Ahmad I, Pant AB, Alhadlaq HA: Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Bioph Res Co 2010, 396:578-583.
27. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
28. Wondrak GT: Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities. Antioxid Redox Sign 2009, 11:3013-3069.
29. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C: Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121:2381-2386.
30. Pelicano H, Carney D, Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Update 2004, 7:97-110.
31. Halliwell B: Oxidative stress and cancer: have we moved forward? Biochem J 2007, 401:1-11.
32. Erez A, Shchelochkov Oleg A, Plon Sharon E, Scaglia F, Lee B: Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism. Am J Hum Genet 2011, 88:402-421.
33. Mao XW, Green LM, Mekonnen T, Lindsey N, Gridley DS: Gene Expression Analysis of Oxidative Stress and Apoptosis in Proton-irradiated Rat Retina. In Vivo 2010, 24:425-430.
34. Kannan K, Jain SK: Oxidative stress and apoptosis. Pathophysiology 2000, 7:153-163.
35. Alemón-Medina R, Bravo-Gómez ME, Gracia-Mora MI, Ruiz-Azuara L: Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells. Toxicol in Vitro 2011, 25:868-873.
36. Alemón-Medina R, Breña-Valle M, Muñoz-Sánchez J, Gracia-Mora M, Ruiz-Azuara L: Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas). Cancer Chemoth Pharm 2007, 60:219-228.
37. Petros RA: Synthesis and Use of Metal Ion-Containing Polymeric Particles. US Patent Appl 61/370,682 2010.
38. An Z, Tang W, Hawker CJ, Stucky GD: One-Step Microwave Preparation of Well-Defined and Functionalized Polymeric Nanoparticles. J Am Chem Soc 2006, 128:15054-15055.